(NASDAQ: PSNL) Personalis's forecast annual revenue growth rate of 23.63% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.86%, and it is also forecast to beat the US market's average forecast revenue growth rate of 23.59%.
Personalis's revenue in 2026 is $69,103,000.On average, 9 Wall Street analysts forecast PSNL's revenue for 2026 to be $7,566,752,080, with the lowest PSNL revenue forecast at $6,657,661,970, and the highest PSNL revenue forecast at $8,858,233,713. On average, 8 Wall Street analysts forecast PSNL's revenue for 2027 to be $9,807,552,193, with the lowest PSNL revenue forecast at $8,938,157,626, and the highest PSNL revenue forecast at $10,723,125,021.
In 2028, PSNL is forecast to generate $11,350,083,718 in revenue, with the lowest revenue forecast at $10,904,285,891 and the highest revenue forecast at $11,683,988,066.